Zobrazeno 1 - 10 of 266 pro vyhledávání: '"Jamalzadeh, S."'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
2
Akademický článek
Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma.
Autor: Lahtinen A; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland., Lavikka K; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland., Virtanen A; Department of Pathology, University of Helsinki and HUS Diagnostic Center, Helsinki University Hospital, 00029 Helsinki, Finland., Li Y; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland., Jamalzadeh S; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland., Skorda A; Cancer Invasion and Resistance Group, Danish Cancer Society Research Center, Strandboulevarden 49, 2100 Copenhagen, Denmark., Lauridsen AR; Cancer Invasion and Resistance Group, Danish Cancer Society Research Center, Strandboulevarden 49, 2100 Copenhagen, Denmark., Zhang K; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland., Marchi G; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland., Isoviita VM; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland., Ariotta V; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland., Lehtonen O; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland., Muranen TA; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland., Huhtinen K; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland; Cancer Research Unit, Institute of Biomedicine and FICAN West Cancer Centre, University of Turku, 20014 Turku, Finland., Carpén O; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland; Department of Pathology, University of Helsinki and HUS Diagnostic Center, Helsinki University Hospital, 00029 Helsinki, Finland., Hietanen S; Department of Obstetrics and Gynaecology, University of Turku and Turku University Hospital, 200521 Turku, Finland., Senkowski W; Biotech Research and Innovation Centre, University of Copenhagen, 2200 Copenhagen, Denmark., Kallunki T; Cancer Invasion and Resistance Group, Danish Cancer Society Research Center, Strandboulevarden 49, 2100 Copenhagen, Denmark; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Häkkinen A; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland., Hynninen J; Department of Obstetrics and Gynaecology, University of Turku and Turku University Hospital, 200521 Turku, Finland., Oikkonen J; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland. Electronic address: jaana.oikkonen@helsinki.fi., Hautaniemi S; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland. Electronic address: sampsa.hautaniemi@helsinki.fi.
Publikováno v: Cancer cell [Cancer Cell] 2023 Jun 12; Vol. 41 (6), pp. 1103-1117.e12. Date of Electronic Publication: 2023 May 18.
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Protecting infrastructure performance from disinformation attacks.
Autor: Jamalzadeh S; School of Industrial and Systems Engineering, University of Oklahoma, Norman, OK, 73019, USA., Barker K; School of Industrial and Systems Engineering, University of Oklahoma, Norman, OK, 73019, USA. kashbarker@ou.edu., González AD; School of Industrial and Systems Engineering, University of Oklahoma, Norman, OK, 73019, USA., Radhakrishnan S; School of Computer Science, University of Oklahoma, Norman, OK, 73019, USA.
Publikováno v: Scientific reports [Sci Rep] 2022 Jul 26; Vol. 12 (1), pp. 12707. Date of Electronic Publication: 2022 Jul 26.
Zobrazit plný text záznamu
7
Akademický článek
QuantISH: RNA in situ hybridization image analysis framework for quantifying cell type-specific target RNA expression and variability.
Autor: Jamalzadeh S; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Häkkinen A; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Andersson N; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Huhtinen K; Institute of Biomedicine and FICAN West Cancer Centre, University of Turku and Turku University Hospital, Turku, Finland., Laury A; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Hietanen S; Department of Obstetrics and Gynecology, University of Turku and Turku University Hospital, Turku, Finland., Hynninen J; Department of Obstetrics and Gynecology, University of Turku and Turku University Hospital, Turku, Finland., Oikkonen J; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Carpén O; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Institute of Biomedicine and FICAN West Cancer Centre, University of Turku and Turku University Hospital, Turku, Finland.; Department of Pathology, University of Helsinki and HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland., Virtanen A; Department of Pathology, University of Helsinki and HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland. anni.virtanen@hus.fi., Hautaniemi S; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland. sampsa.hautaniemi@helsinki.fi.
Publikováno v: Laboratory investigation; a journal of technical methods and pathology [Lab Invest] 2022 Jul; Vol. 102 (7), pp. 753-761. Date of Electronic Publication: 2022 Feb 15.
Zobrazit plný text záznamu
8
Akademický článek
Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer.
Autor: Zhang K; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Erkan EP; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Jamalzadeh S; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Dai J; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Andersson N; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Kaipio K; Cancer Research Unit, Institute of Biomedicine and FICAN West Cancer Centre, University of Turku, Turku, Finland., Lamminen T; Cancer Research Unit, Institute of Biomedicine and FICAN West Cancer Centre, University of Turku, Turku, Finland., Mansuri N; Cancer Research Unit, Institute of Biomedicine and FICAN West Cancer Centre, University of Turku, Turku, Finland., Huhtinen K; Cancer Research Unit, Institute of Biomedicine and FICAN West Cancer Centre, University of Turku, Turku, Finland., Carpén O; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Cancer Research Unit, Institute of Biomedicine and FICAN West Cancer Centre, University of Turku, Turku, Finland.; Department of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki, Finland., Hietanen S; Department of Obstetrics and Gynecology, University of Turku and Turku University Hospital, Turku, Finland., Oikkonen J; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Hynninen J; Department of Obstetrics and Gynecology, University of Turku and Turku University Hospital, Turku, Finland., Virtanen A; Finnish Cancer Registry, Helsinki, Finland.; Department of Pathology, University of Helsinki and HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland., Häkkinen A; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Hautaniemi S; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Vähärautio A; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Publikováno v: Science advances [Sci Adv] 2022 Feb 25; Vol. 8 (8), pp. eabm1831. Date of Electronic Publication: 2022 Feb 23.
Zobrazit plný text záznamu
9
Akademický článek
Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance.
Autor: Pietilä EA; Individualized Drug Therapy Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Gonzalez-Molina J; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Moyano-Galceran L; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Jamalzadeh S; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Zhang K; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Lehtinen L; Research Center for Cancer, Infections and Immunity, Institute of Biomedicine, University of Turku, Turku, Finland., Turunen SP; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Martins TA; Individualized Drug Therapy Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland., Gultekin O; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Lamminen T; Research Center for Cancer, Infections and Immunity, Institute of Biomedicine, University of Turku, Turku, Finland., Kaipio K; Research Center for Cancer, Infections and Immunity, Institute of Biomedicine, University of Turku, Turku, Finland., Joneborg U; Department of Women's and Children's Health, Division Obstetrics and Gynaecology, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden., Hynninen J; Department of Obstetrics and Gynecology, Turku University Hospital, University of Turku, Turku, Finland., Hietanen S; Department of Obstetrics and Gynecology, Turku University Hospital, University of Turku, Turku, Finland., Grénman S; Department of Obstetrics and Gynecology, Turku University Hospital, University of Turku, Turku, Finland., Lehtonen R; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Hautaniemi S; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Carpén O; Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Research Center for Cancer, Infections and Immunity, Institute of Biomedicine, University of Turku, Turku, Finland.; HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland., Carlson JW; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Lehti K; Individualized Drug Therapy Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland. kaisa.lehti@ntnu.no.; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden. kaisa.lehti@ntnu.no.; Department of Biomedical Laboratory Science, Norwegian University of Science and Technology, Trondheim, Norway. kaisa.lehti@ntnu.no.
Publikováno v: Nature communications [Nat Commun] 2021 Jun 23; Vol. 12 (1), pp. 3904. Date of Electronic Publication: 2021 Jun 23.
Zobrazit plný text záznamu
10
Akademický článek
Quantitative analysis of septin Cdc10 & Cdc3-associated proteome during stress response in the fungal pathogen Cryptococcus neoformans.
Autor: Martinez Barrera, Stephani1 (AUTHOR), Hatchell, Emma1 (AUTHOR), Byrum, Stephanie D.2 (AUTHOR), Mackintosh, Samuel G.2 (AUTHOR), Kozubowski, Lukasz1 (AUTHOR) lkozubo@clemson.edu
Publikováno v: PLoS ONE. 12/17/2024, Vol. 19 Issue 12, p1-44. 44p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje